Siobhan P. Purcell

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Journal: BMC medicine
Published: December 13, 2025

Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer.

Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer.

Journal: Cancer communications (London, England)
Published: May 03, 2022

ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Journal: BMC medicine
Published: June 16, 2020

Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.

Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.

Journal: Oncogene
Published: May 13, 2020

Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer.

Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 08, 2017

Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.

Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.

Journal: Journal of the National Cancer Institute
Published: September 04, 2017

Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.

Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.

Journal: Oncogene
Published: March 23, 2017

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors.

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 03, 2015
Showing 1-8 of 8

Last Updated: 09/26/2026